US Stock MarketDetailed Quotes

GILD Gilead Sciences

Watchlist
  • 72.740
  • -0.920-1.25%
Trading Aug 12 15:32 ET
90.56BMarket Cap88.71P/E (TTM)

Gilead Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Gilead Sciences Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings

Aug 8, 2024

Revenue(YoY)

6.95B

+5.38%
EPS(YoY)

1.29

+55.42%
Analyst Rating

Buy

Aug 12, 2024

Gilead Sciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 21 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 7.146B--
--2024/Q3-- / 6.953B--
Aug 8, 20242024/Q26.954B / 6.735B--
Apr 25, 20242024/Q16.686B / 6.349B--
Feb 6, 20242023/Q47.115B / 7.104B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 7.146B--
--2024/Q3-- / 6.953B--
Aug 8, 20242024/Q26.954B / 6.735B--
Apr 25, 20242024/Q16.686B / 6.349B--
Feb 6, 20242023/Q47.115B / 7.104B--

Unlock Free Earnings Estimates

Gilead Sciences Earnings Reports

  • Gilead Sciences | 10-Q: Q2 2024 Earnings Report

    Aug 8 17:20 ET

  • Gilead Sciences | 10-Q: Q1 2024 Earnings Report

    May 8 17:02 ET

  • Gilead Sciences | 10-K: FY2023 Annual Report

    Feb 23 22:39 ET

  • Gilead Sciences | 10-Q: Q3 2023 Earnings Report

    Nov 7, 2023 17:18 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 12, 2024

    Buy

    • Buy

      57.14%

    • Hold

      42.86%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg
    Concept CAR-T Therapy
    CAR-T Therapy
    Intraday-0.48%
    Cancer Research
    Cancer Research
    Intraday-0.50%